Skip to main content
. 2018 Aug 30;11(6):1307–1322. doi: 10.1016/j.tranon.2018.08.001

Table 5.

The Co-Efficient of Drug Interactions (CDI) in MiaPaCa-2 and Panc 05.04 Upon Treatment With ALDH1A1 Specific Inhibitor (A37), in Combination With Gemcitabine, Radiation, and Chemoradiation.

Co-efficient of drug interactions
MiaPaCa-2
Treatment A37 A37 + Gem A37 + Rad A37 + GR CDI
A37 18.22 ± 0.35
Gem 30.94 ± 0.87 39.99 ± 0.76 0.07094
Rad 40.49 ± 1.27 44.27 ± 0.91 0.06001
GR 56.08 ± 1.19 69.22 ± 1.38 0.06774



Panc 05.04
Treatment A37 A37 + Gem A37 + Rad A37 + GR CDI
A37 05.68 ± 0.16
Gem 26.69 ± 3.67 40.53 ± 3.01 0.26735
Rad 24.99 ± 2.34 32.37 ± 1.26 0.22805
GR 29.47 ± 0.77 36.86 ± 2.06 0.22021



MiaPaCa-2 3D culture
A37 (μM) Vol. (μm3) Rad (Gy) Vol. (μm3) CDI
0 137,776,090 8.5 31,224,455
10 142,544,081 8.5 27,296,987 6.133E-09
20 101,913,975 8.5 17,333,234 5.449E-09
40 58,002,988 8.5 5,128,585 2.837E-09

Calculations

CDI = Survival AB/(Survival A x Survival B).

CDI <1, = 1 or >1 indicates that the drugs are synergistic, additive or antagonistic, respectively.

CDI <0.7 indicates that the drug is significantly synergistic.